75N-183H Health-Care Antiseptic Drug Products for OTC Human Use

LET 30 HFD-1 to CTFA and SDA Vol#: 60

LET 31 HFD-1 to Bayer Corporation Vol#: 60

PR 9 Clariant Corporation Vol#: 138

78N-0064 OTC Antiperspirant

ACK 2 HFA-305 Vol#: 17

BKG 1 Background Vol#: 22

96N-0277 Eligibility Criteria for Considering Additional Condition

REF 1 HF-26 Vol#: 3

98D-1146 Microbial effects of antimicrobial new animal drugs/human sa

EAPE20 FDA/Center for Veterinary Medicine Vol#: 4

EAPE21 ChemGen Corp. Vol#: 4

EAPE22 MB Consult Limited Vol#: 4

EAPE23 IDEXX Pharmaceuticals, Inc. Vol#: 4

EAPE24 IDEXX Pharmaceuticals Inc. Vol#: 4

EAPE25 CVM Vol#: 4

EAPE26 Pfizer Inc, Animal Health Group Vol#: 4

EAPE27 USDA-CSREES Vol#: 4

EAPE28 Alliance for the Prudent Use of Antibiot Vol#: 4

EAPE29 National Pork Board Vol#: 4

EAPE30 Perdue Farms Incorporated Vol#: 4

EAPE31 Federation of Animal Science Societies Vol#: 4

EAPE32 Federation of Animal Science Societies Vol#: 4

EAPE33 Federation of Animal Science Societies Vol#: 4

EAPE34 Bayer Animal Health Vol#: 4

EAPE35 FDA/CVM Vol#: 4

EAPE36 CVM/ONADE/HFV-150 Vol#: 4

98N-0583 Exports: Notification and Recordkeeping requirements

REF 2 HF-26 Vol#: 2

00D-0053 Reprocessing&Reuse of Single-Use Devices/Risk Categorization

EC 11 dominican hospital Vol#: 5

EC 12 Brunswick Community Hospital Vol#: 5

EC 13 Middlesex hospital Vol#: 5

EC 14 Columbus County Hospital Vol#: 5

EC 15 operating room nurse Vol#: 5

EC 16 Community Hospital of Monterey Peninsula Vol#: 5

00N-1652 Human Prescripton Drugs/Biologics in Electronic Format

REF 1 HF-26 Vol#: 1

00N-1663 Investigational New Drugs: Export Requirements

C 3 Eli Lilly and Company Vol#: 1

C 4 Bristol-Myers Squibb Vol#: 1

REF 1 HF-26 Vol#: 1

00P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods

C 12679 Annie O'Connor Vol#: 785

EMC 5346 Jeremy Scott Vol#: 785

EMC 5347 Megan Livingston Vol#: 785

EMC 5348 Barbara Labrecque Vol#: 785

01N-0067 Reclassification of Dental Mercury

C 74 Blanche D. Grube, D.M.D. Vol#: 8

C 75 DAMS, Inc. Vol#: 8

C 76 Elizabeth Hopp Vol#: 8

C 77 State Representative Mary Flowers Vol#: 8

C 78 Lee Ann Rudnyk Vol#: 8

C 79 Dr. James E. Rota Vol#: 8

C 80 Linda M. Brocato Vol#: 8

C 81 Carol Ruth Blackman Vol#: 8

C 82 Rebecca L. Griffiths, BS, DMD Vol#: 8

C 83 Carolyn Dohrenwend Vol#: 8

C 84 Representative Hal Lynde Vol#: 8

C 85 Rebecca L. Griffiths, BS, DMD Vol#: 8

C 86 Consumers for Dental Choice Vol#: 8

C 87 Anne Ferreira Vol#: 8

C 88 Form Letter (59) Vol#: 11

C 89 Mary E. Davis Vol#: 13

REF 1 Book Mercury Free Vol#: 12

01N-0322 Institutional Review Boards

REF 1 HF-26 Vol#: 1

01P-0120 Ban Unsafe IV Catheters and other Devices

C 19 Mayo Clinic Vol#: 1

C 20 Medisystems Corporation Vol#: 1

C 21 Becton, Dickinson and Company (BD) Vol#: 1

C 22 Abbott Laboratories Vol#: 1

C 23 American Clinical Laboratory Assn Vol#: 1

C 24 ALARIS Medical Systems, Inc. Vol#: 1

C 25 NAPPSI Vol#: 1

C 26 B. Braun Medical Inc. Vol#: 1

EC 17 NMT Group Vol#: 1

EC 18 Doctors Hospital Vol#: 1

EC 19 America's Blood Centers Vol#: 1

EC 20 American Ambulance Association Vol#: 1

EC 21 American Ambulance Association Vol#: 1

EC 22 Venetec International, Inc. Vol#: 1

EC 23 American Hospital Association Vol#: 1

02D-0333 Juice HACCP Hazards and Controls

EC 1 Number Not Used Vol#: 1

02D-0350 Handling and Retention of Bioavailability and Bioequivalence

C 1 Bristol-Myers Squibb Vol#: 1

C 2 Generic Pharmaceutical Assn Vol#: 1

C 3 Allergan Vol#: 1

02N-0209 Governing First Amendment Case Law

EC 432 Mr. Micah Myers Vol#: 6

EC 433 Retired Vol#: 6

EC 434 Ms. Claire Garden Vol#: 6

EC 435 The Accountability Project Vol#: 6

EC 436 Ms. Tabitha Metreger Vol#: 6

EC 437 Princeton Theological Seminary Student Vol#: 6

EC 438 Dr. Dion Dennis Vol#: 6

02N-0383 Veterinary Adverse Drug Reaction; Product Defect Report

EC 2 Number Not Used Vol#: 1